Stocktoria
INTELLIGENT BIO SOLUTIONS INC. INBS
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-23
INTELLIGENT BIO SOLUTIONS INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Gross margin | 48.6% | 40.8% | 45.8% | 26.0% | — | — | — |
| Operating margin | -299.1% | -349.8% | -330.5% | -1002.1% | -1907.1% | -281.4% | -1513.7% |
| Net margin | -294.9% | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% | -1676.2% |
| FCF margin | -285.9% | -324.6% | -314.7% | — | — | — | — |
| Return on assets | -104.1% | -128.1% | -73.7% | -102.7% | -67.2% | -32.2% | -127.8% |
| Return on equity | -225.6% | -352.7% | -121.9% | -279.9% | -125.4% | -46.7% | 60.7% |
| Current ratio | 1.44 | 0.77 | 1.57 | 0.66 | 2.33 | 4.94 | 0.30 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.